Molina Healthcare
About: Molina Healthcare Inc offers healthcare plans focused on Medicaid-related solutions for low-income families and individuals. Its health plans are operated by a network of subsidiaries, each of which is licensed as a health maintenance organization (HMO). It has four segments: Medicaid, Medicare, Marketplace and Others. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. The Other segment, which is insignificant to its consolidated results of operations, includes long-term services and supports consultative services in Wisconsin. It generates majority revenue from Medicaid segment.
Employees: 18,000
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
41% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 71
3% more funds holding
Funds holding: 604 [Q3] → 622 (+18) [Q4]
2% less repeat investments, than reductions
Existing positions increased: 226 | Existing positions reduced: 230
3.62% less ownership
Funds ownership: 94.26% [Q3] → 90.65% (-3.62%) [Q4]
19% less capital invested
Capital invested by funds: $19B [Q3] → $15.5B (-$3.56B) [Q4]
23% less call options, than puts
Call options by funds: $67.1M | Put options by funds: $87.3M
43% less funds holding in top 10
Funds holding in top 10: 7 [Q3] → 4 (-3) [Q4]
Research analyst outlook
8 Wall Street Analysts provided 1 year price targets over the past 3 months
8 analyst ratings
Barclays Andrew Mok 38% 1-year accuracy 22 / 58 met price target | 15%upside $362 | Equal-Weight Maintained | 25 Apr 2025 |
Bernstein Lance Wilkes 100% 1-year accuracy 3 / 3 met price target | 32%upside $414 | Outperform Initiated | 22 Apr 2025 |
Baird Michael Ha 45% 1-year accuracy 10 / 22 met price target | 19%upside $375 | Neutral Downgraded | 15 Apr 2025 |
Truist Securities David Macdonald 54% 1-year accuracy 54 / 100 met price target | 27%upside $400 | Buy Maintained | 11 Apr 2025 |
Mizuho Ann Hynes 43% 1-year accuracy 9 / 21 met price target | 27%upside $400 | Outperform Maintained | 9 Apr 2025 |
Financial journalist opinion
Based on 15 articles about MOH published over the past 30 days
